Background illustration for clinical trials search

Paid Clinical Trials Boca Raton

Discover 2,023 paid clinical trials in Boca Raton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Miami FL, Nashville TN, Fairfax VA, Houston TX,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase 1, Phase 2, Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Miami FL, Tampa FL, Nashville TN, Columbus OH,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase 1, Recruiting

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

for
Neoplasms, Chemotherapy-induced Nausea and Vomiting
Location: Miami FL, Orlando FL
Sponsor: University of Central Florida

Sex: All

Age: 60+

Code: NCT05838638

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Miami FL, Tampa FL, Newnan GA, Fairfax VA,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase 3, Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: Miami FL, Charleston SC, Atlanta GA, Durham NC,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse

for
Multiple Myeloma
Location: Miami FL
Sponsor: Dickran Kazandjian, MD

Sex: All

Age: 0+

Code: NCT06910124

Phase 2, Recruiting

A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

for
Crohn's Disease
Location: Lighthouse PT FL, Miami FL, Palmetto Bay FL,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06958536

Phase 2, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Miami FL, Jacksonville FL, Greenville SC,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase 3, Recruiting

Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML

for
Advanced MDS, AML
Location: Miami FL
Sponsor: Immune System Key Ltd

Sex: All

Age: 18+

Code: NCT04365179

Phase 1, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Miami FL, Jacksonville FL, Atlanta GA, Charlotte NC,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06615479

Phase 3, Recruiting

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

for
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell,
Location: Miami FL, Birmingham AL, Philadelphia PA, Cleveland OH,
Sponsor: Oncotartis, Inc.

Sex: All

Age: 18+

Code: NCT03921879

Phase 1, Recruiting

Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib

for
Healthy, Hepatic Impairment
Location: Miami FL, Orlando FL, San Antonio TX
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18 - 70+

Code: NCT06997276

Phase 1, Recruiting

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma,
Location: Miami FL, Houston TX, Lake Success NY, Dallas TX,
Sponsor: PanTher Therapeutics

Sex: All

Age: 18+

Code: NCT06673017

Phase 1, Recruiting

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

for
Gastrointestinal Stromal Tumor (GIST)
Location: Miami FL, Jacksonville FL, Nashville TN, New York NY,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06630234

Phase 1, Phase 2, Recruiting

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

for
Neoplasms, Arteriovenous Malformation of Central Nervous System,
Location: Miami FL, Detroit MI
Sponsor: The Radiosurgery Society

Sex: All

Age: 0+

Code: NCT01885299

Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for
Myelodysplastic Syndromes, Cytopenia
Location: Miami FL, Tampa FL, Memphis TN, Bethesda MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT04419649

Phase 2, Recruiting

Florida Community-Engaged Research Alliance (FL-CEAL)

for
Health, Subjective
Location: Miami FL, Gainesville FL, Jacksonville FL
Sponsor: University of Miami

Sex: All

Age: 13+

Code: NCT06829485

Recruiting

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

for
Metabolic Associated Fatty Liver Disease,
Location: Miami FL, Columbus OH, Bellaire TX, San Antonio TX
Sponsor: Foundation for the National Institutes of Health

Sex: All

Age: 18 - 70+

Code: NCT07122700

Recruiting

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma
Location: Miami FL, Jacksonville FL, Atlanta GA, Durham NC,
Sponsor: Replimune Inc.

Sex: All

Age: 0+

Code: NCT06581406

Phase 2, Phase 3, Recruiting

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Miami FL, Orlando FL, Winter Park FL,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 65

Code: NCT07096674

Phase 2, Recruiting